Kathleen Moore, MD
Fred & Pamela Buffett Cancer Center
Topic Presenter
Biography
Dr. Kathleen N. Moore, MD, MS, FASCO is an internationally known gynecologic oncologist with expertise in drug development from Phase 1-3. She has led practice changing trials for PARPi and Antibody Drug Conjugates and is interested in personalized selection and sequencing of medicines for patients with gynecologic cancers. She also is passionate about mentoring the next generation of clinical trialists.
Financial Disclosure
Aadi, Astra Zeneca, Abbvie, BioNTech, Duality, Daiichi Sankyo, Allarity, GSK, Immunogen, Regeneron, Schrodinger, Whitehawk, TeneoSeven, Context, Accent
Researcher
Aadi, Astra Zeneca, Abbvie, BeOne, BioNTech, Corcept, Duality, Daiichi-Sankyo, Genmab, Gilead, GSK, Incyte, Immunogen, Janssen, Kivu, Lilly, Merck, PMV, Pfizer, Regeneron, Takeda, Tubulis, Verastem, Whitehawk, Zentalis, Zymeworks
Advisor
Research to Practice, GLC, PRIME, Peer View
Speaker
Up To Date
Royalties
Associate Director, GOG Partners
Professional Service